ENTITY

Zogenix Inc (ZGNX US)

2
Analysis
Health CareUnited States
Zogenix, Inc. is a specialty pharmaceutical company with proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. The Company's products candidates include a product that enables needle-free subcutaneous delivery of sumatriptan for the treatment of acute migraine.
more
Refresh
15 Jun 2020 12:13

SK Biopharm Valuation Analysis (What Is the Market Implying from SK Holdings?)

In this insight, we provide a valuation analysis of SK Biopharmaceuticals (BIO SK).Bullish Case Valuation - If we take a bullish case valuation...

Logo
320 Views
Share
19 May 2020 22:44

SK Biopharm IPO Preview

SK Biopharmaceuticals (BIO SK) is getting ready to complete an IPO in the Korean stock market in June. The SK Biopharm will be one of the biggest...

Logo
214 Views
Share
No more insights
x